Speaker

Rob Berlin, JD

HEAD - U.S. REGULATORY POLICY, GSK
Washington DC, District of Columbia, United States
Rob Berlin is the Head of U.S. Regulatory Policy at GlaxoSmithKline (GSK). Rob leads a team focused on driving U.S. regulatory policy, advocacy, and intelligence activities, to ensure optimal advancement and lifecycle management of GSK’s product portfolio. Rob came to GSK from the FDA where he most recently served as the Director of the Division of Clinical Policy within the Office of New Drug (OND) Policy, an office he helped to establish as a founding member of the leadership team. Prior to joining OND Policy, Rob worked in CDRH, FDA’s Office of Policy, and in the Office of Chief Counsel. He began his career at Hogan & Hartson (now Hogan Lovells) after completing his law degree and M.P.H. in Epidemiology at the University of Minnesota.
Speaking In
1:45 PM - 2:45 PM
Wednesday, June 7
This session will review exciting developments in cloud-based submissions which are now a reality…